Latest debt-to-equity ratio
Viridian Therapeutics Debt-to-equity ratio
Direct answer
Viridian Therapeutics's debt-to-equity ratio is 36.96%.
The verified market snapshot reports 36.96%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 36.96%
Explore related company data
View Viridian Therapeutics's market capitalizationView Viridian Therapeutics's price-to-book ratioView Viridian Therapeutics's return on equityView Viridian Therapeutics's dividend yieldView Viridian Therapeutics's 52-week price rangeView Viridian Therapeutics's revenue growthView Viridian Therapeutics's profit marginView all Viridian Therapeutics key metricsReturn to Viridian Therapeutics profile